RELATIONSHIP BETWEEN DAILY DOSING FREQUENCY, COMPLIANCE, HEALTHCARE RESOURCE USE, AND COSTS- EVIDENCE FROM THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Author(s)
Toy EL1, Beaulieu NU2, McHale JM2, Welland TR1, Plauschinat C3, Swensen A3, Duh MS21Analysis Group, Lakewood, CO, USA, 2Analysis Group, Boston, MA, USA, 3Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA
Presentation Documents
OBJECTIVES: To assess the relationship between the daily dosing frequency (DDF) of COPD pharmacotherapies and treatment compliance; to estimate the effect of compliance on healthcare resource utilization (HCRU) and costs. METHODS: COPD patients were identified using a health insurance claims database covering 8 million lives (1999-2006). Patients were stratified based on the recommended DDF (QD, BID, TID, QID) of their first COPD drug claim post COPD diagnosis. Compliance was measured using proportion of days covered (PDC). HCRU outcomes included inpatient days and medical visits (inpatient, outpatient, and emergency room). A multivariate regression model assessed the relationship between compliance and one-year HCRU controlling for demographics, comorbidities, and baseline resource use. Unit healthcare costs were obtained from the 2005 Medical Expenditure Panel Survey data and adjusted to 2008 dollars. Total costs were modeled by multiplying unit costs by the observed HCRU. RESULTS: Sample sizes ranged from 3,678 (QD) to 25,011 (BID). Compliance was strongly correlated with DDF: PDC over one year for QD, BID, TID, and QID patients was 43%, 37%, 30%, and 23%, respectively (all p<0.001 vs. QD). Multivariate analysis showed that one-year compliance was correlated with HCRU. For 1,000 COPD patients, a 5 percentage point increase in PDC reduced the number of inpatient visits by 2.5%, hospital inpatient days by 3.1%, and emergency room visits by 1.8%; the estimated number of outpatient visits increased by 0.2% (p<0.001 for all comparisons). This increase in compliance yielded approximately $300,000 in cost savings from decreased HCRU. CONCLUSIONS: COPD patients who initiated treatment with QD dosing had significantly higher compliance than those with more frequent dosings. Patients with higher compliance were found to incur fewer hospital- and emergency room-related visits. In a hypothetical cohort of 1,000 COPD patients, increasing PDC by 5 percentage points would save $300,000 per year, mostly from reduced hospital visits.
Conference/Value in Health Info
2010-05, ISPOR 2010, Atlanta, GA, USA
Value in Health, Vol. 13, No. 3 (May 2010)
Code
PRS31
Topic
Patient-Centered Research
Topic Subcategory
Adherence, Persistence, & Compliance
Disease
Respiratory-Related Disorders